[HTML][HTML] Serum tumor markers for detection of hepatocellular carcinoma

L Zhou, J Liu, F Luo - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors and is the
second most common cause of cancer death in China. Therefore, it is very important to …

Biomarkers for hepatocellular carcinoma

T Behne, MS Copur - International journal of hepatology, 2012 - Wiley Online Library
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and
carries a poor survival rate. The management of patients at risk for developing HCC remains …

Tissue-and serum-associated biomarkers of hepatocellular carcinoma

R Chauhan, N Lahiri - Biomarkers in cancer, 2016 - journals.sagepub.com
Hepatocellular carcinoma (HCC), one of the leading causes of cancer deaths in the world, is
offering a challenge to human beings, with the current modes of treatment being a palliative …

[PDF][PDF] Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis

WL Ma, CL Hsu, CC Yeh, MH Wu, CK Huang… - …, 2012 - Wiley Online Library
Early reports suggested androgen/androgen receptor (AR) signals promote
hepatocarcinogenesis. However, all antiandrogen clinical trials failed in advanced …

Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence

A Singhal, M Jayaraman, DN Dhanasekaran… - Critical reviews in …, 2012 - Elsevier
With increased understanding of cancer biology, a multitude of pathological, genetic, and
molecular events that drive hepatocarcinogenesis, including angiogenesis, invasion, and …

Ferredoxin 1 is essential for embryonic development and lipid homeostasis

S Mohibi, Y Zhang, V Perng, M Chen, J Zhang, X Chen - Elife, 2024 - elifesciences.org
Abstract Mammalian ferredoxin 1 and 2 (FDX1/2) belong to an evolutionary conserved
family of iron-sulfur cluster containing proteins and act as electron shutters between …

AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis

J Jin, X Niu, L Zou, L Li, S Li, J Han, P Zhang, J Song… - Cancer letters, 2016 - Elsevier
Circulating tumor cells (CTCs) quantification may be helpful for evaluating cancer
dissemination, predicting prognosis and assessing therapeutic effectiveness and safety. In …

[HTML][HTML] 肝细胞癌生物标志物的研究进展

王嘉倍, 刘连新 - 世界华人消化杂志, 2005 - wjgnet.com
原发性肝癌(primary hepatic cancer, PHC) 是世界范围内第8 位最常见的恶性肿瘤,
在我国肝细胞癌(hepatocellular carcinoma, HCC) 占其91.5%. HCC 是肿瘤病因学中的重要 …

Biomarkers for virus-induced hepatocellular carcinoma (HCC)

S Mathew, A Ali, H Abdel-Hafiz, K Fatima… - Infection, Genetics and …, 2014 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and is
advanced by severe viral hepatitis B or C (HBV or HCV) as well as alcoholic liver disease …

Increased expression of circulating cancer stem cell markers during the perioperative period predicts early recurrence after curative resection of hepatocellular …

GH Choi, GI Kim, JE Yoo, DC Na, DH Han… - Annals of surgical …, 2015 - Springer
Background This study was designed to investigate the correlation between postoperative
recurrence of hepatocellular carcinoma (HCC) and perioperative expression and dynamic …